Loss of ARID1A was proven to be related to high PD-L1 expression in multiple cancers, including non-small cell lung cancer (33), gastric cancer (34), ovarian cancer (35), colorectal cancer (36), and hepatocellular carcinoma (37). Here, ARID1A is linked to ovarian carcinoma.